Skip to main content

Find Clinical Trials

Home
Conditions
Slow Virus Diseases

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies

Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Completed

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

NCT01499199

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site Providence, Rhode Island, United States

View Trial Details

Completed

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)

NCT00632073

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

NCT00857298

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Body Weight, +27 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Raltegravir Switch for Toxicity or Adverse Events

NCT00958100

Conditions: Acquired Immunodeficiency Syndrome, Antiretroviral Therapy, Blood-Borne Infections, +15 more
Locations: Policlinico A. Gemelli Rome, Italy

View Trial Details

Completed

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

NCT00386633

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: LMU-Munich, Department of Infectious Diseases and Tropical Medicine Munich, Germany

View Trial Details

Completed

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

NCT01533259

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Kaiser Permanente Los Angeles Los Angeles, California, United States

Peter J. Ruane, MD, Inc. Los Angeles, California, United States

Anthony Mills MD, Inc Los Angeles, California, United States

Dupont Circle Physician's Group Washington D.C., District of Columbia, United States

View Trial Details

Completed

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV

NCT01433185

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +18 more
Locations: Kenya Medical Research Institute, Family AIDS Care and Education Services Kisumu, Nyanza, Kenya

View Trial Details

Completed

Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya

NCT01891409

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Homa Bay District Hospital Homa Bay, Kenya

View Trial Details

Completed

Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision

NCT01186575

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +22 more
Locations: Nyanza Reproductive Health Society Kisumu, Nyanza, Kenya

View Trial Details

Completed

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NCT00002336

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Univ of Arizona / Health Science Ctr Tucson, Arizona, United States

California Med Research Group Fresno, California, United States

HIV Research Group San Diego, California, United States

Saint Francis Mem Hosp San Francisco, California, United States

View all 22 locations

View Trial Details